Fig. 3From: A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicalsDetermining the strength of the evidence for the association between exposures and (adverse) effect. Evidence is characterized as “strong”, “moderate”, “weak,” or “no data”. If in vitro or in silico data is considered strong, upgrade “weak” to “moderate”, or “moderate” to “strong”Back to article page